Literature DB >> 12803945

Systemic and discoid lupus erythematosus in HIV-infected patients treated with highly active antiretroviral therapy.

Leonardo Calza1, Roberto Manfredi, Vincenzo Colangeli, Antonietta D'Antuono, Beatrice Passarini, Francesco Chiodo.   

Abstract

Although HIV infection is often associated with several rheumatic diseases, the coexistence of this retroviral infection and systemic lupus erythematosus (SLE) is extremely uncommon. Generally, HIV-related immunosuppression improves SLE symptoms, and antiretroviral therapy may lead to an autoimmune disease flare subsequent to the increase of circulating CD4+ cell number. Two HIV-infected female patients with SLE and discoid lupus erythematosus (DLE) diagnosed a few months after the highly active antiretroviral therapy initiation, are described. To our knowledge, this is the second case of DLE and the twenty-seventh case of SLE reported to date in association with HIV infection.

Entities:  

Mesh:

Year:  2003        PMID: 12803945     DOI: 10.1258/095646203321605585

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  22 in total

Review 1.  Susceptibility of patients with rheumatic diseases to B-cell non-Hodgkin lymphoma.

Authors:  Catarina Dias; David A Isenberg
Journal:  Nat Rev Rheumatol       Date:  2011-06       Impact factor: 20.543

2.  [Immune reconstitution syndrome].

Authors:  D Meyer-Olson; D Ernst; M Stoll
Journal:  Z Rheumatol       Date:  2012-04       Impact factor: 1.372

Review 3.  Antibody polyspecificity and neutralization of HIV-1: a hypothesis.

Authors:  Barton F Haynes; M Anthony Moody; Laurent Verkoczy; Garnett Kelsoe; S Munir Alam
Journal:  Hum Antibodies       Date:  2005

4.  Human immunodeficiency virus infection and autoimmune hepatitis during highly active anti-retroviral treatment: a case report and review of the literature.

Authors:  Hanady Daas; Riad Khatib; Haitham Nasser; Farah Kamran; Martha Higgins; Louis Saravolatz
Journal:  J Med Case Rep       Date:  2011-06-25

5.  An autoreactive antibody from an SLE/HIV-1 individual broadly neutralizes HIV-1.

Authors:  Mattia Bonsignori; Kevin Wiehe; Sebastian K Grimm; Rebecca Lynch; Guang Yang; Daniel M Kozink; Florence Perrin; Abby J Cooper; Kwan-Ki Hwang; Xi Chen; Mengfei Liu; Krisha McKee; Robert J Parks; Joshua Eudailey; Minyue Wang; Megan Clowse; Lisa G Criscione-Schreiber; M Anthony Moody; Margaret E Ackerman; Scott D Boyd; Feng Gao; Garnett Kelsoe; Laurent Verkoczy; Georgia D Tomaras; Hua-Xin Liao; Thomas B Kepler; David C Montefiori; John R Mascola; Barton F Haynes
Journal:  J Clin Invest       Date:  2014-03-10       Impact factor: 14.808

Review 6.  Human Ig knockin mice to study the development and regulation of HIV-1 broadly neutralizing antibodies.

Authors:  Laurent Verkoczy; Frederick W Alt; Ming Tian
Journal:  Immunol Rev       Date:  2017-01       Impact factor: 12.988

Review 7.  Autoreactivity in HIV-1 broadly neutralizing antibodies: implications for their function and induction by vaccination.

Authors:  Laurent Verkoczy; Marilyn Diaz
Journal:  Curr Opin HIV AIDS       Date:  2014-05       Impact factor: 4.283

Review 8.  Disorders of immune reconstitution in patients with HIV infection responding to antiretroviral therapy.

Authors:  Martyn A French
Journal:  Curr HIV/AIDS Rep       Date:  2007-02       Impact factor: 5.071

Review 9.  Humanized Immunoglobulin Mice: Models for HIV Vaccine Testing and Studying the Broadly Neutralizing Antibody Problem.

Authors:  Laurent Verkoczy
Journal:  Adv Immunol       Date:  2017       Impact factor: 3.543

Review 10.  Systemic lupus erythematosus and HIV infection: a whimsical relationship. Reports of two cases and review of the literature.

Authors:  Manuela Carugati; Marco Franzetti; Alessandro Torre; Riccardo Giorgi; Augusto Genderini; Francesco Strambio de Castilla; Cristina Gervasoni; Agostino Riva
Journal:  Clin Rheumatol       Date:  2013-05-07       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.